Previous reports from melanoma, NSCLC, and mismatch-repair deficient carcinomas also indicate that some tumors harboring extremely elevated mutational load do not derive clear benefit from PD-1 and CTLA-4 blockade12,13,16. Here, CTLA4 is linked to non-small cell lung carcinoma.